People are running their own experiments with GLP-1s — with stunning results
Sobre este episodio
<p>From <a href="https://podcasts.apple.com/us/podcast/apple-news-in-conversation/id1577591053?i=1000776173199"><em>Apple News In Conversation</em></a>: GLP-1 drugs like Ozempic and Wegovy are being taken by millions of Americans. These medications have been approved for treating diabetes, obesity, and a small number of other chronic conditions. But even as experts are still learning how the drugs work, many people have found that they help with other disorders — from addiction to brain fog to arthritis — where anecdotal evidence is promising but the formal research hasn’t caught up. <a href="https://www.juliabelluz.com/" target="_blank" rel="noopener noreferrer">Julia Belluz</a>, a contributing writer for the <em>New York Times</em> Opinion section and coauthor of <a href="https://books.apple.com/us/book/food-intelligence/id6739794014" target="_blank" rel="noopener noreferrer"><em>Food Intelligence</em></a>, joins <em>Apple News In Conversation</em> guest host David Greene to explain why what’s unfolding right now may be the largest uncontrolled drug experiment in modern history.</p>
Escucha este episodio en inglés para aprender inglés
Los episodios de podcast son una de las formas más densas de absorber inglés al ritmo nativo. People are running their own experiments with GLP-1s — with stunning results de Apple News Today te da diálogo natural, habla sin guion y vocabulario que de verdad aparece en conversaciones reales.
En la app Hinto, cada palabra de la transcripción es tocable. Toca una palabra desconocida, ve la traducción a tu idioma al instante y sigue escuchando sin romper el ritmo.
Episodios para aprender inglés
- The brutal reality check awaiting Democrats 6 nov 2026
- How Trump’s electoral coalition fell apart 5 nov 2026
- A seismic Democratic win breaks Trump's grip on power 4 nov 2026
- Inside the decision team the country relies on for election results 3 nov 2026
- A shock endorsement shakes up Michigan’s pivotal Senate race 2 nov 2026
- Have chocolate companies quietly changed their recipes? 31 oct 2026
- Inside the allegations that Democrats stacked Alaska’s ballot 30 oct 2026
- Election Day is fast approaching. These are the races to watch. 29 oct 2026
- Government corruption is animating voters. Texas shows why. 28 oct 2026
- Anthropic warned that AI could end humanity. Now it’s racing to go public. 27 oct 2026
- Trump’s and Obama’s dueling rallies in a crucial swing state 26 oct 2026
- The strange new politics of the death penalty 24 oct 2026
- The scramble to save the internet from a catastrophic threat 23 oct 2026
- The billionaires behind the record midterm ad blitz 22 oct 2026
- What’s behind the youth protests sweeping Europe? 21 oct 2026
- Three world powers could decide Ukraine’s future. Kyiv won’t be in the room. 20 oct 2026
- What’s really driving a long-shot push to break up Canada 19 oct 2026
- Your biggest midterm questions, answered 17 oct 2026
- Iran’s plan to sway the U.S. elections 16 oct 2026
- Prices keep climbing. Frustrated voters may take it out on Republicans. 15 oct 2026
- The scandals that forced Trump to oust Ambassador Guilfoyle 14 oct 2026
- DHS agents search Ilhan Omar’s home — weeks before an election 13 oct 2026
- Trump’s surprise deal with Putin sparks Republican outrage 12 oct 2026
- The Cornell case exposes a dark reality about college culture 10 oct 2026
- Why some Republicans are getting worried about Texas 9 oct 2026
- Lawyers share Christa Pike’s first words since waking — and make her case in court 8 oct 2026
- Tennessee failed to execute Christa Pike. Now she’s conscious. 7 oct 2026
- The Cornell case puts New York’s consent laws in the spotlight 6 oct 2026
- How a Boeing jet survived a nosedive at extreme speed 5 oct 2026
- Americans want more kids. Here’s what’s stopping them. 3 oct 2026